New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S2994

Introduced
9/22/22  

Caption

Concerns annual reporting requirements of SHBP and SEHBP commissions.

Impact

The introduction of this bill directly influences the way state-sponsored health benefits are managed, promoting a more structured and informed approach towards the health benefits of state employees and school employees. By instituting annual reports, the bill is expected to improve the quality of oversight and provide stakeholders, including the Governor and the Legislature, with clearer data regarding the health benefits plans. Additionally, public access to these reports is expected to foster greater transparency and community involvement in discussions surrounding health benefits. Public hearings following report releases allow for citizen input, which further strengthens the participative governance framework.

Summary

S2994 seeks to enhance the accountability and transparency of the State Health Benefits Commission and the School Employees' Health Benefits Commission by implementing annual reporting requirements. The bill mandates that each commission publishes a comprehensive rate setting recommendation analysis report, which must be prepared by an actuarial firm. This report will consist of several elements, including the plan overview for the upcoming year, trend analysis, financial projections, and any other relevant exhibits that support the report's findings. The report aims to provide detailed insights into the financial health and operational considerations of the health benefits plans they administer.

Contention

There may be points of contention surrounding the additional administrative burdens that may come with the reporting requirements. Opponents of the bill could argue that the resources required for producing these annual reports might detract from the commissions' core functions, potentially leading to inefficiencies. Furthermore, the participation of the public in hearings could lead to intense scrutiny and debate around the financial decisions made by the commissions. The balance between accountability through public reporting and the operational effectiveness of the commissions will likely be a significant talking point in discussions around the bill.

Companion Bills

NJ A4700

Same As Concerns annual reporting requirements of SHBP and SEHBP commissions.

Previously Filed As

NJ S250

Concerns annual reporting requirements of SHBP and SEHBP commissions.

NJ A1802

Concerns annual reporting requirements of SHBP and SEHBP commissions.

NJ S2995

Requires study and implementation of reference-based pricing for SHBP and SEHBP.

NJ A1074

Requires SHBP and SEHBP commissions to use funds from 2025 False Claims Act settlement with Horizon to lower public employee health care contribution costs.

NJ S4282

"Property Tax Relief Act"; makes various changes to SHBP and SEHBP administration and limits reimbursement for certain medical procedures.

NJ A5086

"Property Tax Relief Act"; makes various changes to SHBP and SEHBP administration and limits reimbursement for certain medical procedures.

NJ A3369

Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.

NJ A1965

Prohibits insurers, SHBP, and SEHBP from charging fee for paper bills and notices.

NJ A2625

Requires employers other than State who participate in SHBP and employers who participate in SEHBP to remain enrolled in program for minimum of five years.

NJ A4238

Requires Treasury to regularly review contract and performance of pharmacy benefits manager for SHBP and SEHBP.

Similar Bills

US HR198

Providing for the expenses of certain committees of the House of Representatives in the One Hundred Nineteenth Congress.

MN HC1

A house concurrent resolution relating to the regent nomination joint committee.

IL HR0020

HOUSE RULES-AMEND

CA AB1350

Employment Development Department: policies and practices.

NM HJM2

Combine Standing & Interim Committees

MN HC2

A House concurrent resolution relating to the adjournment of the House of Representatives and Senate until 2026.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

AR HB1573

To Reorganize The Standing Committees And The Subject Matter Interim Committees Of The House Of Representatives.